AGER and Alzheimer disease: Focusing on transporters involved in AD, Son et al. [124] modified MSCs to express the secreted isoform of RAGE (sRAGE), which inhibits the interaction between RAGE and its ligands, thus preventing the adverse effects of this signaling pathway.